Follow
Hesam Montazeri
Title
Cited by
Cited by
Year
Network-based integration of multi-omics data for prioritizing cancer genes
C Dimitrakopoulos, SK Hindupur, L Häfliger, J Behr, H Montazeri, MN Hall, ...
Bioinformatics 34 (14), 2441-2448, 2018
1462018
Continuous state/action reinforcement learning: A growing self-organizing map approach
H Montazeri, S Moradi, R Safabakhsh
Neurocomputing 74 (7), 1069-1082, 2011
342011
Hepatocellular carcinoma xenografts established from needle biopsies preserve the characteristics of the originating tumors
T Blumer, I Fofana, MS Matter, X Wang, H Montazeri, D Calabrese, ...
Hepatology communications 3 (7), 971-986, 2019
282019
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients
N Beerenwinkel, H Montazeri, H Schuhmacher, P Knupfer, V von Wyl, ...
PLoS computational biology 9 (8), e1003203, 2013
282013
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites
S Iketani, SJ Hong, J Sheng, F Bahari, B Culbertson, FF Atanaki, ...
Cell Host & Microbe 30 (10), 1354-1362. e6, 2022
252022
On BCG vaccine protection from COVID-19: a review
N Bagheri, H Montazeri
SN Comprehensive Clinical Medicine 3, 1261-1271, 2021
212021
Large-scale inference of conjunctive Bayesian networks
H Montazeri, J Kuipers, R Kouyos, J Böni, S Yerly, T Klimkait, V Aubert, ...
Bioinformatics 32 (17), i727-i735, 2016
202016
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
S Srivatsa, H Montazeri, G Bianco, M Coto-Llerena, M Marinucci, CKY Ng, ...
Nature communications 13 (1), 7748, 2022
142022
PipeIT: a singularity container for molecular diagnostic somatic variant calling on the ion torrent next-generation sequencing platform
A Garofoli, V Paradiso, H Montazeri, PM Jermann, G Roma, L Tornillo, ...
The Journal of Molecular Diagnostics 21 (5), 884-894, 2019
132019
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
G Bianco, M Coto-Llerena, J Gallon, V Kancherla, S Taha-Mehlitz, ...
Communications biology 5 (1), 373, 2022
92022
Estimating HIV-1 fitness characteristics from cross-sectional genotype data
S Gopalakrishnan, H Montazeri, S Menz, N Beerenwinkel, W Huisinga
PLoS computational biology 10 (11), e1003886, 2014
72014
Estimating the dynamics and dependencies of accumulating mutations with applications to HIV drug resistance
H Montazeri, HF Günthard, WL Yang, R Kouyos, N Beerenwinkel, ...
Biostatistics 16 (4), 713-726, 2015
52015
Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C
S Posada-Céspedes, G Van Zyl, H Montazeri, J Kuipers, SY Rhee, ...
PLoS Computational Biology 17 (9), e1008363, 2021
42021
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens
H Montazeri, M Coto-Llerena, G Bianco, E Zangene, S Taha-Mehlitz, ...
Nucleic acids research 49 (15), 8488-8504, 2021
32021
Bayesian reconstruction of transmission trees from genetic sequences and uncertain infection times
H Montazeri, S Little, M Mozaffarilegha, N Beerenwinkel, V DeGruttola
Statistical applications in genetics and molecular biology 19 (4-6), 20190026, 2020
32020
Uncovering hidden cancer self-dependencies through analysis of shRNA-level dependency scores
Z Toghrayee, H Montazeri
Scientific Reports 14 (1), 856, 2024
12024
SL-scan identifies synthetic lethal interactions in cancer using metabolic networks
E Zangene, SA Marashi, H Montazeri
Scientific Reports 13 (1), 15763, 2023
12023
Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens
M Karimpour, M Totonchi, M Behmanesh, H Montazeri
Life Science Alliance 7 (1), 2024
2024
Somatic Single-Nucleotide Variant Calling from Single-Cell DNA Sequencing Data Using SCAN-SNV
S Bahonar, H Montazeri
Variant Calling: Methods and Protocols, 267-277, 2022
2022
MDM2 INHIBITOR RESPONSE PREDICTION METHOD
S Piscuoglio, C NG KIU Yan, G Bianco, H Montazeri, N Beerenwinkel, ...
WO Patent WO2021228814A1, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20